home / stock / bsem / bsem news

BSEM News and Press, BioStem Technologies Inc From 11/08/23

Stock Information
Company Name: BioStem Technologies Inc
Stock Symbol: BSEM
Market: OTC
Website: biostemtechnologies.com
Menu
BSEM BSEM Quote BSEM Short BSEM News BSEM Articles BSEM Message Board
Get BSEM Alerts

News, Short Squeeze, Breakout and More Instantly...
BSEM - BioStem Technologies Awarded Q Code for VENDAJE AC® Line from Centers for Medicare and Medicaid Services

POMPANO BEACH, Fla., Nov. 08, 2023 (GLOBE NEWSWIRE) -- BioStem Technologies Inc . (OTC:BSEM), a leading regenerative medicine company focused on the development, manufacture and commercialization of placental-derived biologics for advanced wound care, today announced that the Centers for ...
BSEM - BioStem Technologies to Report Third Quarter 2023 Financial Results on Tuesday, November 14, 2023

POMPANO BEACH, FL / ACCESSWIRE / November 6, 2023 / BioStem Technologies Inc. (OTC PINK:BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics for advanced wound care, announced today that it plans to release i...

BSEM - BioStem Technologies Closes Oversubscribed $2M Private Placement

POMPANO BEACH, Fla., Nov. 03, 2023 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics for advanced wound care, today announces that it has closed an oversu...

BSEM - BioStem Technologies Announces Opening of First Clinical Site for Diabetic Foot Ulcer Study

Study to support differentiated efficacy of Vendaje ® structural tissue allograft POMPANO BEACH, FL / ACCESSWIRE / October 24, 2023 / BioStem Technologies Inc. (OTC PINK:BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...
BSEM - BioStem Technologies to Highlight Core Advanced Wound Care Portfolio at SAWC Fall 2023 Conference

POMPANO BEACH, FL / ACCESSWIRE / October 17, 2023 / BioStem Technologies Inc. (OTC PINK:BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, today announced that it will highlight the...

BSEM - BioStem Technologies: CMS Decision a "Win For Patients"

POMPANO BEACH, FL / ACCESSWIRE / September 29, 2023 / BioStem Technologies Inc. (OTC PINK:BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics for advanced wound care, today hails a decision by the Centers fo...

BSEM - BioStem Receives IRB Approval for Clinical Study to Evaluate Vendaje(R) in Diabetic Foot Ulcers

POMPANO BEACH, FL / ACCESSWIRE / September 26, 2023 / BioStem Technologies Inc. (OTC PINK:BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics for advanced wound care, announced today the approval of an Inves...
BSEM - BioStem Technologies Initiates Nationwide Launch of AmnioWrap2(TM) with Venture Medical

Leading wound market solutions provider will lead BioStem's commercialization of AmnioWrap2™ AmnioWrap2 is a versatile allograft solution for wound applications POMPANO BEACH, FL / ACCESSWIRE / September 19, 2023 / BioStem Technologies Inc. (OTC PINK:BSEM), a leading regenerativ...

BSEM - BioStem Technologies Engages PCG Advisory for Strategic Investor Relations

POMPANO BEACH, FL / ACCESSWIRE / September 18, 2023 / BioStem Technologies Inc. (OTC PINK: BSEM ), an innovator in the development, manufacture, and commercialization of allografts for regenerative therapies, has engaged PCG Advisory, Inc. , a leading investor relations and digital strategi...

BSEM - NovaBay Pharmaceuticals Announces Agreement with BioStem Technologies to Commercialize Amniotic Tissue Allograft as Avenova® Allograft

NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) and BioStem Technologies, Inc. (OTC: BSEM) announce an agreement under which NovaBay has been granted the right to commercialize BioStem Technologies’ Amniotic Tissue Allograft, which is intended for use as a protective covering during the...
Previous 10 Next 10